Long term noninvasive respiratory support in children with OSA-I and OSA-II: Data of a nation-wide study.

IF 3.8 2区医学 Q1 CLINICAL NEUROLOGY

Sleep medicine Pub Date : 2024-11-29 DOI:10.1016/j.sleep.2024.11.039

Chiara Tommesani, Sonia Khirani, Alessandro Amaddeo, Bruno Massenavette, Priscille Bierme, Jessica Taytard, Nathalie Stremler, Melisande Baravalle-Einaudi, Julie Mazenq, Iulia Ioan, Cyril Schweitzer, Marie Emilie Lampin, Alexandra Binoche, Clemence Mordacq, Jean Bergounioux, Blaise Mbieleu, Robert Rubinsztajn, Elodie Sigur, Geraldine Labouret, Aline Genevois, Arnaud Becourt, Eglantine Hullo, Isabelle Pin, Stéphane Debelleix, François Galodé, Stéphanie Bui, Johan Moreau, Marie Catherine Renoux, Stefan Matecki, Marc Lubranno Lavadera, Rachel Heyman, Michael Pomedio, Laurence Le Clainche, Plamen Bokov, Alexandra Masson, Pauline Hangard, Celine Menetrey, Mikael Jokic, Elsa Gachelin, Caroline Perisson, Anne Pervillé, Agnes Fina, Lisa Giovannini-Chami, Emmanuelle Fleurence, Audrey Barzic, Audrey Breining, Morgane Ollivier, Guillaume Labbé, Laurianne Coutier, Guillaume Aubertin, Brigitte Fauroux

{"title":"Long term noninvasive respiratory support in children with OSA-I and OSA-II: Data of a nation-wide study.","authors":"Chiara Tommesani, Sonia Khirani, Alessandro Amaddeo, Bruno Massenavette, Priscille Bierme, Jessica Taytard, Nathalie Stremler, Melisande Baravalle-Einaudi, Julie Mazenq, Iulia Ioan, Cyril Schweitzer, Marie Emilie Lampin, Alexandra Binoche, Clemence Mordacq, Jean Bergounioux, Blaise Mbieleu, Robert Rubinsztajn, Elodie Sigur, Geraldine Labouret, Aline Genevois, Arnaud Becourt, Eglantine Hullo, Isabelle Pin, Stéphane Debelleix, François Galodé, Stéphanie Bui, Johan Moreau, Marie Catherine Renoux, Stefan Matecki, Marc Lubranno Lavadera, Rachel Heyman, Michael Pomedio, Laurence Le Clainche, Plamen Bokov, Alexandra Masson, Pauline Hangard, Celine Menetrey, Mikael Jokic, Elsa Gachelin, Caroline Perisson, Anne Pervillé, Agnes Fina, Lisa Giovannini-Chami, Emmanuelle Fleurence, Audrey Barzic, Audrey Breining, Morgane Ollivier, Guillaume Labbé, Laurianne Coutier, Guillaume Aubertin, Brigitte Fauroux","doi":"10.1016/j.sleep.2024.11.039","DOIUrl":null,"url":null,"abstract":"Purpose: The aim of the study was to analyze the characteristics of otherwise healthy children with obstructive sleep apnea (OSA; OSA-I) and children with OSA and non-syndromic obesity (OSA-II) treated with long term continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV) in 2019 in France.Methods: Data were collected from a national survey on paediatric home noninvasive ventilatory support. CPAP/NIV initiation criteria and duration, age at CPAP/NIV initiation, equipment used and CPAP/NIV settings, and objective compliance were analyzed.Results: Patients with OSA-I and OSA-II represented 6 % (n = 84, 71 % males) and 10 % (n = 144, 72 % males) of the national cohort, respectively. The apnea-hypopnea index (63 % vs 76 %), alone or combined with nocturnal gas exchange (25 % vs 21 %, for OSA-II and OSA-I patients respectively) were used as initiation criteria of CPAP/NIV. OSA-II patients were older at CPAP/NIV initiation (mean age 11.0 ± 4.0 vs 6.8 ± 4.5 years, p < 0.001) and were treated for a longer time (2.3 ± 2.6 vs 1.3 ± 1.5 years, p = 0.008) than OSA-I patients. NIV was used in 6 % of OSA-I patients and 13 % of OSA-II patients (p = 0.142). Both groups used preferentially a nasal mask. Mean CPAP level was higher in OSA-II patients as compared to OSA-I patients (8.7 ± 2.0 vs 7.7 ± 2.4 cmH2O, p = 0.02). Objective compliance was comparable (mean use 6.8 ± 2.6 vs 5.9 ± 3.0 h/night in OSA-I and OSA-II, respectively, p = 0.054).Conclusion: Six and 10 % of children treated with long term CPAP/NIV in France in 2019 had OSA-I and OSA-II, respectively. Both groups were preferentially treated with CPAP and were comparable except for age, with OSA-II patients being older at CPAP/NIV initiation.","PeriodicalId":21874,"journal":{"name":"Sleep medicine","volume":"126 ","pages":"67-72"},"PeriodicalIF":3.8000,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.sleep.2024.11.039","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: The aim of the study was to analyze the characteristics of otherwise healthy children with obstructive sleep apnea (OSA; OSA-I) and children with OSA and non-syndromic obesity (OSA-II) treated with long term continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV) in 2019 in France.

Methods: Data were collected from a national survey on paediatric home noninvasive ventilatory support. CPAP/NIV initiation criteria and duration, age at CPAP/NIV initiation, equipment used and CPAP/NIV settings, and objective compliance were analyzed.

Results: Patients with OSA-I and OSA-II represented 6 % (n = 84, 71 % males) and 10 % (n = 144, 72 % males) of the national cohort, respectively. The apnea-hypopnea index (63 % vs 76 %), alone or combined with nocturnal gas exchange (25 % vs 21 %, for OSA-II and OSA-I patients respectively) were used as initiation criteria of CPAP/NIV. OSA-II patients were older at CPAP/NIV initiation (mean age 11.0 ± 4.0 vs 6.8 ± 4.5 years, p < 0.001) and were treated for a longer time (2.3 ± 2.6 vs 1.3 ± 1.5 years, p = 0.008) than OSA-I patients. NIV was used in 6 % of OSA-I patients and 13 % of OSA-II patients (p = 0.142). Both groups used preferentially a nasal mask. Mean CPAP level was higher in OSA-II patients as compared to OSA-I patients (8.7 ± 2.0 vs 7.7 ± 2.4 cmH₂O, p = 0.02). Objective compliance was comparable (mean use 6.8 ± 2.6 vs 5.9 ± 3.0 h/night in OSA-I and OSA-II, respectively, p = 0.054).

Conclusion: Six and 10 % of children treated with long term CPAP/NIV in France in 2019 had OSA-I and OSA-II, respectively. Both groups were preferentially treated with CPAP and were comparable except for age, with OSA-II patients being older at CPAP/NIV initiation.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Sleep medicine 医学-临床神经学

CiteScore

8.40

自引率

6.20%

发文量

1060

审稿时长

49 days

期刊介绍： Sleep Medicine aims to be a journal no one involved in clinical sleep medicine can do without. A journal primarily focussing on the human aspects of sleep, integrating the various disciplines that are involved in sleep medicine: neurology, clinical neurophysiology, internal medicine (particularly pulmonology and cardiology), psychology, psychiatry, sleep technology, pediatrics, neurosurgery, otorhinolaryngology, and dentistry. The journal publishes the following types of articles: Reviews (also intended as a way to bridge the gap between basic sleep research and clinical relevance); Original Research Articles; Full-length articles; Brief communications; Controversies; Case reports; Letters to the Editor; Journal search and commentaries; Book reviews; Meeting announcements; Listing of relevant organisations plus web sites.